Problems of stopping trials early Journal Articles

authors

• Guyatt, Gordon
• Briel, Matthias
• Glasziou, P
• Bassler, D
• Montori, VM

status

• published 

publication date

• June 15, 2012

has subject area

• 1103 Clinical Sciences (FoR)
• 1117 Public Health and Health Services (FoR)
• Adrenergic beta-Antagonists (MeSH)
• Clinical Trials Data Monitoring Committees (MeSH)
• Critical Illness (MeSH)
• Decision Making (MeSH)
• Endpoint Determination (MeSH)
• Ethics, Research (MeSH)
• General & Internal Medicine (Science Metrix)
• Humans (MeSH)
• Insulin (MeSH)
• Myocardial Infarction (MeSH)
• Protein C (MeSH)
• Randomized Controlled Trials as Topic (MeSH)
• Research Design (MeSH)
• Sepsis (MeSH)
• Surgical Procedures, Operative (MeSH)
• Time Factors (MeSH)
• Treatment Outcome (MeSH)

published in

• The BMJ  Journal

keywords

• Adrenergic beta-Antagonists
• Clinical Trials Data Monitoring Committees
• Critical Illness
• Decision Making
• Endpoint Determination
• Ethics, Research
• Humans
• Insulin
• Myocardial Infarction
• Protein C
• Randomized Controlled Trials as Topic
• Research Design
• Sepsis
• Surgical Procedures, Operative
• Time Factors
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1136/bmj.e3863

PubMed ID

• 22705814

start page

• e3863

end page

• e3863

volume

• 344

issue

• jun15 1